BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31384856)

  • 21. P-glycoprotein mediates efflux transport of darunavir in human intestinal Caco-2 and ABCB1 gene-transfected renal LLC-PK1 cell lines.
    Fujimoto H; Higuchi M; Watanabe H; Koh Y; Ghosh AK; Mitsuya H; Tanoue N; Hamada A; Saito H
    Biol Pharm Bull; 2009 Sep; 32(9):1588-93. PubMed ID: 19721237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
    Dahan A; Sabit H; Amidon GL
    Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interplay between CYP3A-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal epithelial Caco-2 (TC7) cell monolayers.
    Raeissi SD; Hidalgo IJ; Segura-Aguilar J; Artursson P
    Pharm Res; 1999 May; 16(5):625-32. PubMed ID: 10350002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular Uptake and Transport Characteristics of FL118 Derivatives in Caco-2 Cell Monolayers.
    Zhou Y; Hu W; Zhang X; Wang Y; Zhuang W; Li F; Li Q
    Chem Pharm Bull (Tokyo); 2021; 69(11):1054-1060. PubMed ID: 34719586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 7,8-Dihydroxyflavone leads to survival of cultured embryonic motoneurons by activating intracellular signaling pathways.
    Tsai T; Klausmeyer A; Conrad R; Gottschling C; Leo M; Faissner A; Wiese S
    Mol Cell Neurosci; 2013 Sep; 56():18-28. PubMed ID: 23500004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of ochratoxin A with human intestinal Caco-2 cells: possible implication of a multidrug resistance-associated protein (MRP2).
    Berger V; Gabriel AF; Sergent T; Trouet A; Larondelle Y; Schneider YJ
    Toxicol Lett; 2003 Apr; 140-141():465-76. PubMed ID: 12676495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carrier mechanisms involved in the transepithelial transport of bis(POM)-PMEA and its metabolites across Caco-2 monolayers.
    Annaert P; Van Gelder J; Naesens L; De Clercq E; Van den Mooter G; Kinget R; Augustijns P
    Pharm Res; 1998 Aug; 15(8):1168-73. PubMed ID: 9706045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An in vitro and in silico study on the flavonoid-mediated modulation of the transport of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through Caco-2 monolayers.
    Schutte ME; Freidig AP; van de Sandt JJ; Alink GM; Rietjens IM; Groten JP
    Toxicol Appl Pharmacol; 2006 Dec; 217(2):204-15. PubMed ID: 16997339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal transport of bis(12)-hupyridone in Caco-2 cells and its improved permeability by the surfactant Brij-35.
    Yu H; Hu YQ; Ip FC; Zuo Z; Han YF; Ip NY
    Biopharm Drug Dispos; 2011 Apr; 32(3):140-50. PubMed ID: 21271607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal transport of irinotecan in Caco-2 cells and MDCK II cells overexpressing efflux transporters Pgp, cMOAT, and MRP1.
    Luo FR; Paranjpe PV; Guo A; Rubin E; Sinko P
    Drug Metab Dispos; 2002 Jul; 30(7):763-70. PubMed ID: 12065434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer resistance protein BCRP (ABCG2)-mediated transepithelial nitrofurantoin secretion and its regulation in human intestinal epithelial (Caco-2) layers.
    Wright JA; Haslam IS; Coleman T; Simmons NL
    Eur J Pharmacol; 2011 Dec; 672(1-3):70-6. PubMed ID: 22004608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
    Profit L; Eagling VA; Back DJ
    AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MRP2 mediated drug-drug interaction: indomethacin increases sulfasalazine absorption in the small intestine, potentially decreasing its colonic targeting.
    Dahan A; Amidon GL
    Int J Pharm; 2010 Feb; 386(1-2):216-20. PubMed ID: 19944137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on intestinal absorption of sulpiride (2): transepithelial transport of sulpiride across the human intestinal cell line Caco-2.
    Watanabe K; Sawano T; Endo T; Sakata M; Sato J
    Biol Pharm Bull; 2002 Oct; 25(10):1345-50. PubMed ID: 12392092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human organic anion-transporting polypeptide OATP-A (SLC21A3) acts in concert with P-glycoprotein and multidrug resistance protein 2 in the vectorial transport of Saquinavir in Hep G2 cells.
    Su Y; Zhang X; Sinko PJ
    Mol Pharm; 2004 Jan; 1(1):49-56. PubMed ID: 15832500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transepithelial transport of phenolic acids in Flos Lonicerae Japonicae in intestinal Caco-2 cell monolayers.
    Zhou W; Shan J; Wang S; Cai B; Di L
    Food Funct; 2015 Sep; 6(9):3072-80. PubMed ID: 26213252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The transepithelial transport mechanism of polybrominated diphenyl ethers in human intestine determined using a Caco-2 cell monolayer.
    Yu Y; Wang M; Zhang K; Yang D; Zhong Y; An J; Lei B; Zhang X
    Environ Res; 2017 Apr; 154():93-100. PubMed ID: 28056407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of dietary plant flavonoids on 7,8-dihydroxyflavone transepithelial transport in human intestinal Caco-2 cells.
    Chen Y; Xia G; Wang C; Wu H; Xu X; Mao G; Wu J; Zhao Z
    Food Sci Nutr; 2023 Nov; 11(11):6888-6898. PubMed ID: 37970375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional characterization of peptide transporters in MDCKII-MDR1 cell line as a model for oral absorption studies.
    Agarwal S; Jain R; Pal D; Mitra AK
    Int J Pharm; 2007 Mar; 332(1-2):147-52. PubMed ID: 17097248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Use of Transporter Probe Drug Cocktails for the Assessment of Transporter-Based Drug-Drug Interactions in a Clinical Setting-Proposal of a Four Component Transporter Cocktail.
    Ebner T; Ishiguro N; Taub ME
    J Pharm Sci; 2015 Sep; 104(9):3220-8. PubMed ID: 25981193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.